Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2 Acetamido 2 Deoxy D Glucose
2. 2 Acetamido 2 Deoxyglucose
3. 2-acetamido-2-deoxy-d-glucose
4. 2-acetamido-2-deoxyglucose
5. Acetylglucosamine
6. N Acetyl D Glucosamine
7. N-acetyl-d-glucosamine
1. Acetylglucosamine
2. N-acetyl-beta-d-glucosamine
3. N-acetylglucosamine
4. Beta-n-acetylglucosamine
5. Betaglcnac
6. Chebi:28009
7. Glcnac-beta
8. 14131-68-1
9. 2-acetamido-2-deoxy-beta-d-glucosamine
10. N-[(2r,3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
11. 2-acetamido-2-deoxy-beta-d-glucose
12. N-acetyl Glucosamine
13. 103094-10-6
14. 85409-09-2
15. 8p59336f68
16. 72-87-7
17. 125304-10-1
18. 137630-09-2
19. 1398-61-4
20. Nacglc
21. Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-(dinonylphenoxy)-, Branched
22. Cheon Shim Bo Yun
23. N-acetyl-b-d-glucosamine
24. 2-acetamido-2-deoxyhexopyranose
25. Hydrolyzed Chitin
26. Pharmaceutical Aid
27. Ssglcnac-r
28. Crab Shell Chitin
29. B-n-acetylglucosamine
30. Beta-n-acetylglucosamin
31. Spectrum_000999
32. Spectrum2_001353
33. Spectrum3_001400
34. Spectrum4_001179
35. B-n-acetyl-d-glucosamine
36. Bmse000231
37. Epitope Id:135813
38. Beta-n-acetyl-d-glucosamine
39. Schembl19345
40. Bspbio_003020
41. Kbiogr_001817
42. Kbioss_001479
43. Divk1c_000352
44. Spectrum1500715
45. N-acetyl-.beta.-d-glucosamine
46. Spbio_001565
47. Chembl447878
48. Beta-n-acetyl-delta-glucosamine
49. Schembl21358982
50. Chebi:17029
51. Hms501b14
52. Kbio1_000352
53. Kbio2_001479
54. Kbio2_004047
55. Kbio2_006615
56. Kbio3_002240
57. .beta.-n-acetylglucosamin
58. [4)-beta-d-glcpnac(1->]n
59. 2-acetamido-2-deoxy-b-d-glucose
60. Ninds_000352
61. Dtxsid301045979
62. Hms1921e22
63. Unii-8p59336f68
64. N-acetyl-d-glucosamine, Usp Grade
65. Zinc3983907
66. Bdbm50481442
67. Ccg-39291
68. Akos015960418
69. At21015
70. Beta-1,4-poly-n-acetyl-d-glucosamine
71. 2-acetamido-2-deoxy-beta-delta-glucose
72. Idi1_000352
73. N-[(2r,3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]acetamide
74. Ncgc00178341-01
75. [1,4-(n-acetyl-beta-d-glucosaminyl)]n
76. 2-deoxy-2-acetamido-beta-d-glucopyranose
77. Ac-11093
78. (1->4)-2-acetamido-2-deoxy-beta-d-glucan
79. 2-(acetylamino)-2-deoxy-beta-d-glucopyranose
80. 2-acetamido-2-deoxy-.beta.-d-glucose
81. 12a176
82. C03878
83. Glucopyranose, 2-acetamido-2-deoxy-, Beta-d-
84. N-acetyl-d-glucosamine (complete Stereochemistry)
85. Q284367
86. 2-acetamido-2-deoxy-.beta.-d-glucopyranose
87. Glucopyranose, 2-acetamido-2-deoxy-, .beta.-d-
88. 2-acetamido-2-deoxy-d-glucosen-acetyl-beta-d-glucosamine
89. Poly-(b1-4)-n-acetyl Glucosamine/poly-(a1-4)-n-acetyl Glucosamine
90. Wurcs=2.0/1,1,0/[a2122h-1b_1-5_2*ncc/3=o]/1/
Molecular Weight | 221.21 g/mol |
---|---|
Molecular Formula | C8H15NO6 |
XLogP3 | -1.7 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 221.08993720 g/mol |
Monoisotopic Mass | 221.08993720 g/mol |
Topological Polar Surface Area | 119 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 235 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A N-Acetylglucosamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Acetylglucosamine, including repackagers and relabelers. The FDA regulates N-Acetylglucosamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Acetylglucosamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of N-Acetylglucosamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A N-Acetylglucosamine supplier is an individual or a company that provides N-Acetylglucosamine active pharmaceutical ingredient (API) or N-Acetylglucosamine finished formulations upon request. The N-Acetylglucosamine suppliers may include N-Acetylglucosamine API manufacturers, exporters, distributors and traders.
click here to find a list of N-Acetylglucosamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A N-Acetylglucosamine DMF (Drug Master File) is a document detailing the whole manufacturing process of N-Acetylglucosamine active pharmaceutical ingredient (API) in detail. Different forms of N-Acetylglucosamine DMFs exist exist since differing nations have different regulations, such as N-Acetylglucosamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N-Acetylglucosamine DMF submitted to regulatory agencies in the US is known as a USDMF. N-Acetylglucosamine USDMF includes data on N-Acetylglucosamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N-Acetylglucosamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N-Acetylglucosamine suppliers with USDMF on PharmaCompass.
N-Acetylglucosamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Acetylglucosamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Acetylglucosamine GMP manufacturer or N-Acetylglucosamine GMP API supplier for your needs.
A N-Acetylglucosamine CoA (Certificate of Analysis) is a formal document that attests to N-Acetylglucosamine's compliance with N-Acetylglucosamine specifications and serves as a tool for batch-level quality control.
N-Acetylglucosamine CoA mostly includes findings from lab analyses of a specific batch. For each N-Acetylglucosamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Acetylglucosamine may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Acetylglucosamine EP), N-Acetylglucosamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Acetylglucosamine USP).
LOOKING FOR A SUPPLIER?